1.
NC Osuji, I Del Giudice, E Matutes, AC Wotherspoon, C Dearden, D Catovsky. The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53. Haematologica 2005;90(10):1435-1436; https://doi.org/10.3324/%x.